[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$clym](/topic/$clym)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CLYM Clinical Data Update: On October XX 2025 Climb Bio Inc. announced new long-term follow-up clinical data for their drug budoprutug showing effective control of proteinuria in four patients over three years without severe adverse events. This event is significant for investors as it highlights potential advancements in treatment for B-cell mediated diseases but it also carries risks related to regulatory approvals and competition"  
[X Link](https://x.com/USCorpFilings/status/1979147902774648854) [@USCorpFilings](/creator/x/USCorpFilings) 2025-10-17T11:30Z 6245 followers, XXX engagements


"Climb Bio: Long-term follow-up clinical data for budoprutug anti-CD19 monoclonal antibody support potential for therapeutic benefit in primary membranous nephropathy (pMN) $CLYM #ClimbBio"  
[X Link](https://x.com/HottestStockNow/status/1979144359707648371) [@HottestStockNow](/creator/x/HottestStockNow) 2025-10-17T11:16Z 2716 followers, XX engagements


"$CLYM to Present Data at American Society of Nephrology (ASN) Kidney Week 2025"  
[X Link](https://x.com/doepke_michel/status/1979141027106582901) [@doepke_michel](/creator/x/doepke_michel) 2025-10-17T11:02Z 5636 followers, XXX engagements


"$CLYM -BTIG reiterates Climb Bio $X target Buy -William Blair initiates coverage at Outperform via @WilliamBlair"  
[X Link](https://x.com/MarcJacksonLA/status/1978878361477980441) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-16T17:39Z 7578 followers, XXX engagements